Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06052319 · ClinicalTrials.gov registry record
A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
A clinical trial of Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD), sponsored by Janssen Scientific Affairs.
- Completed
- Registry status
- 277
- Enrollment target
- 6
- Study locations
NCT06052319 is a study of Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD) that has completed, run by Janssen Scientific Affairs. The registered enrollment target is 277 participants, below the 1,089-participant average among 5 other Coronary Artery Disease (CAD) trials with a reported enrollment target (75% lower). The trial reports 6 study locations across 4 states.
The verdict
NCT06052319, a study of Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD), has completed, sponsored by Janssen Scientific Affairs.
- COMPLETED
- Registry status
- 277 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to assess the engagement and usefulness of Care4Today® Connect CAD-PAD digital platform in participants with coronary artery disease or peripheral artery disease (CAD or PAD).
Conditions Studied
Interventions
- DEVICE Care4Today® Connect CAD-PAD Mobile Application
Study Locations (6)
Florida
- HCA Florida Memorial Hospital - Jacksonville
- University of Florida Health Jacksonville - Jacksonville
Texas
- HCA Houston Healthcare Medical Center - Houston
- Rio Grande Regional Hospital - McAllen
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Kansas
- The Kansas City Heart Rhythm Institute - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2023-11-29 |
| Est. Completion | 2024-08-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06052319
The ClinicalTrials.gov registry entry for NCT06052319 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 277 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,089-participant average among 5 other Coronary Artery Disease (CAD) trials with a reported enrollment target (75% lower). The listed sponsor is Janssen Scientific Affairs, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Coronary Artery Disease (CAD) appearing as the primary indexed condition, and to 1 intervention - of which Care4Today® Connect CAD-PAD Mobile Application is the first listed.
NCT06052319 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Florida, Texas, Colorado.
Frequently Asked Questions
What is clinical trial NCT06052319 about?
NCT06052319 is a clinical study titled "A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population". The purpose of this study is to assess the engagement and usefulness of Care4Today® Connect CAD-PAD digital platform in participants with coronary artery disease or peripheral artery disease (CAD or PAD).
What is the current status of trial NCT06052319?
This trial is currently completed. The enrollment target is 277 participants. The study started on 2023-11-29. Estimated completion is 2024-08-13.
What conditions does trial NCT06052319 study?
This clinical trial studies the following conditions: Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD).
What interventions are being tested in trial NCT06052319?
The interventions under investigation include: Care4Today® Connect CAD-PAD Mobile Application (DEVICE).
Who is sponsoring clinical trial NCT06052319?
This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06052319 being conducted?
This trial has 6 study locations across Colorado, Florida, Kansas, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease (CAD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
RECRUITING
-
Using CTA Measures to Define Cardiac Risk In NFL Alumni
RECRUITING
-
Beating the Blues for Your Heart
COMPLETED · Phase 2
-
Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
COMPLETED
-
Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus
COMPLETED · Phase 4
Explore more on PlainTrial
Coronary Artery Disease (CAD)
All registered trials for this condition
Peripheral Artery Disease (PAD)
All registered trials for this condition
Colorado
All trials with a study site in Colorado
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.